Health TrialsbyHealthPanel

Deep Iliacus Plane Block Versus Transmuscular Quadratus Lumborum Block for Postoperative Analgesia After Total Hip Arthroplasty

ConditionsDeep Iliacus Plane BlockTransmuscular Quadratus Lumborum BlockPostoperative AnalgesiaTotal Hip Arthroplasty
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorTanta University

About this trial

This study aims to compare the analgesic efficacy, opioid consumption, motor function preservation, and quality of recovery of ultrasound-guided deep iliacus plane block (DIPB) and transmuscular quadratus lumborum block (QLB) in patients undergoing total hip arthroplasty (THA).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥ 18 years.

Both sexes.

American Society of Anesthesiologists (ASA) physical status I-III.

Scheduled for elective unilateral total hip arthroplasty (THA) under spinal anesthesia.

Disqualifiers

Known allergy to local anesthetics or study medications.

Coagulopathy or anticoagulant therapy contraindicating regional anesthesia.

Infection at the site of injection.

Pre-existing neurological deficits affecting the lower limbs.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Deep iliacus plane block

    Drug

    Patients will receive ultrasound-guided deep iliacus plane block (DIPB) using 25 mL of 0.25% bupivacaine.

  • Quadratus lumborum block

    Drug

    Patients will receive ultrasound-guided transmuscular quadratus lumborum block (QLB) using 25 mL of 0.25% bupivacaine.

Treatment groups

80 Participants
are divided into 2 treatment groups
Group A: Group DIPBExperimental treatment 1 intervention
Group B: Group QLBExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Degree of pain

Time frame
Each patient will be instructed about postoperative pain assessment with VAS. VAS (0 represents "no pain" while 10 represents "the worst pain imaginable"). VAS will be assessed at post-anesthesia care unit (PACU), 2, 4, 6, 12, and 24 h postoperatively.

Secondary outcomes

1

Total morphine consumption

Rescue analgesia of morphine will be given as 3 mg bolus if the Visual Analog Scale (VAS) \> 3 to be repeated after 30 min if pain persists until the VAS \< 4.

Time frame
24 hours postoperatively
2

Time to the 1st rescue analgesia

Time to the first request for the rescue analgesia will be recorded from the end of block to first dose of morphine administrated.

Time frame
24 hours postoperatively
3

Time for ambulation

Time to ambulation: the time interval (in hours) from the end of surgery to the first successful mobilization of the patient, defined as the ability to stand and walk at least 3-5 steps with or without assistance

Time frame
24 hours postoperatively
4

Length of hospital stay

Length of hospital stay will be recorded from admission till the discharge from hospital.

Time frame
24 hours postoperatively

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Tanta University

Lead sponsor

Source ClinicalTrials.gov
Apply now